Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse, Cepheid Set Distribution Pact

NEW YORK (GenomeWeb News) – Prodesse will distribute Cepheid’s SmartCycler System and related products in the US under a new non-exclusive agreement, Milwaukee, Wis.-based Prodesse said today.

Prodesse’s ProFlu+ Assay and three other assays have been cleared by the Food and Drug Administration for use with the SmartCycler, and other tests are in the pipeline, the company said.

"Many of the top 100 hospitals in the country already have moved to molecular detection for influenza," Prodesse President and CEO Tom Shannon said in a statement. "This distribution agreement allows us to better serve clinical lab customers as more and more of them seek to implement products like ProFlu+."

Financial and other terms of the distribution pact were not disclosed.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.